Trial intelligence / Profile preview

IV Lidocaine for Pain After Laparoscopic TEP Inguinal Hernioplasty

NCT02601651Phase 4Completed

Sponsor
B.P. Koirala Institute of Health Sciences
Start
Dec 2015
Primary completion
Mar 2017
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial in postoperative pain comparing Lidocaine with Placebo (2 arms). Primary endpoint: Total morphine requirement during the first 24 h postoperatively. Started Dec 2015; status: completed.

02

Drugs

Lidocaine Hydrochloride Injection, without epinephrine
03

Conditions

postoperative pain

Beyond the preview

Go deeper on NCT02601651.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02601651.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call